高级检索
当前位置: 首页 > 详情页

Recapitulating and Correcting Marfan Syndrome in a Cellular Model.

文献详情

资源类型:
Pubmed体系:
机构: [1]Faculty of Health Sciences, University of Macau, Taipa, Macau, China. [2]Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, Connecticut, USA. [3]Agricultural Genomes Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen, China. [4]Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, Guangdong, China. [5]School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, State Key Laboratory Cultivation Base and Key Laboratory of Vision Science, Ministry of Health and Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, Wenzhou, Zhejiang, China. [6]Yunnan Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China. [7]Stowers Institute for Medical Research, Kansas City, Missouri, USA. [8]Department of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut, USA.
出处:

关键词: Marfan syndrome human pluripotent stem cells disease modeling genome editing osteogenesis smooth muscle

摘要:
Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in FBN1 gene, which encodes a key extracellular matrix protein FIBRILLIN-1. The haplosufficiency of FBN1 has been implicated in pathogenesis of MFS with manifestations primarily in cardiovascular, muscular, and ocular tissues. Due to limitations in animal models to study the late-onset diseases, human pluripotent stem cells (PSCs) offer a homogeneic tool for dissection of cellular and molecular pathogenic mechanism for MFS in vitro. Here, we first derived induced PSCs (iPSCs) from a MFS patient with a FBN1 mutation and corrected the mutation, thereby generating an isogenic "gain-of-function" control cells for the parental MFS iPSCs. Reversely, we knocked out FBN1 in both alleles in a wild-type (WT) human embryonic stem cell (ESC) line, which served as a loss-of-function model for MFS with the WT cells as an isogenic control. Mesenchymal stem cells derived from both FBN1-mutant iPSCs and -ESCs demonstrated reduced osteogenic differentiation and microfibril formation. We further demonstrated that vascular smooth muscle cells derived from FBN1-mutant iPSCs showed less sensitivity to carbachol as demonstrated by contractility and Ca2+ influx assay, compared to the isogenic controls cells. These findings were further supported by transcriptomic anaylsis of the cells. Therefore, this study based on both gain- and loss-of-function approaches confirmed the pathogenetic role of FBN1 mutations in these MFS-related phenotypic changes.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 3 区 生化与分子生物学
最新[2023]版:
大类 | 2 区 生物学
小类 | 2 区 生化与分子生物学
第一作者:
第一作者机构: [1]Faculty of Health Sciences, University of Macau, Taipa, Macau, China.
共同第一作者:
通讯作者:
通讯机构: [1]Faculty of Health Sciences, University of Macau, Taipa, Macau, China. [2]Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, Connecticut, USA. [8]Department of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut, USA. [*1]Faculty of Health Sciences, University of Macau, Taipa, Macau, China [*2]Department of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号